Crinetics Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Complete ESG assessment of Crinetics Pharmaceuticals Inc can be accessed by logging in. This webpage is a zero-cost Sustainability assessment covering Crinetics Pharmaceuticals Inc. The Sustainability assessment for Crinetics Pharmaceuticals Inc indicates its transparency towards the UN SDGs.
Crinetics Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.0; made up of an environmental score of 3.2, social score of 1.6 and governance score of 4.0.
3.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1760 | Protagenic Therapeutics Inc | 3.1 | Medium |
| 1760 | Vcanbio Cell & Gene Engineering Corp Ltd | 3.1 | Medium |
| 1800 | Crinetics Pharmaceuticals Inc | 3.0 | Medium |
| 1800 | Allergan plc | 3.0 | Medium |
| 1800 | Aptevo Therapeutics Inc | 3.0 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Crinetics Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Crinetics Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Crinetics Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Crinetics Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Crinetics Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Crinetics Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Crinetics Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). The company is also developing CRN04777, an oral selective nonpeptide somatostatin type 5 receptor agonist, which is in phase I clinical trial for the treatment of congenital hyperinsulinism; and CRN04894, an oral adrenocorticotrophic hormone antagonist that is in phase I clinical trial for the treatment of Cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.